
Struggling with math? Study shows a gentle electric jolt boosts arithmetic by up to 29pc — but only for some
A new study published yesterday in PLOS Biology suggests that mild electrical stimulation can boost arithmetic performance — and offers fresh insight into the brain mechanisms behind mathematical ability, along with a potential way to optimise learning.
The findings could eventually help narrow cognitive gaps and help build a more intellectually equitable society, the authors argue.
'Different people have different brains, and their brains control a lot in their life,' said Roi Cohen Kadosh, a neuroscientist at the University of Surrey who led the research.
'We think about the environment — if you go to the right school, if you have the right teacher — but it's also our biology.'
Cohen Kadosh and colleagues recruited 72 University of Oxford students, scanning their brains to measure connectivity between three key regions.
Participants then tackled math problems that required either calculating answers or recalling memorised solutions.
They found that stronger connections between the dorsolateral prefrontal cortex, which governs executive function, and the posterior parietal cortex, involved in memory, predicted better calculation performance.
When the researchers applied a painless form of brain stimulation using electrode-fitted caps — a technique known as transcranial random noise stimulation — the low performers saw their scores jump by 25-29 per cent.
The team believes the stimulation works by enhancing the excitability of neurons and interacting with GABA, a brain chemical that inhibits excessive activity — effectively compensating for weak neural connectivity in some participants.
In fact, the stimulation helped underperformers reach or even surpass the scores of peers with naturally stronger brain wiring. But those who already performed well saw no benefit.
'Some people struggle with things, and if we can help their brain to fulfil their potential, we open them a lot of opportunities that otherwise would be closed,' said Cohen Kadosh, calling it an 'exciting time' for the field of brain stimulation research.
Still, he flagged a key ethical concern: the risk that such technologies could become more available to those with financial means, widening — rather than closing — access gaps.
He also urged the public not to try this at home. 'Some people struggle with learning, and if our research proves successful beyond the lab, we could help them fulfil their ambitions and unlock opportunities that might otherwise remain out of reach.' — AFP
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Free Malaysia Today
7 hours ago
- Free Malaysia Today
Pharma shares slump after Trump price threat
Donald Trump is targeting cutting US drug prices, which are among the world's highest. (AFP pic) PARIS : Shares in European pharmaceutical firms slumped on Friday following a threat by president Donald Trump to punish them if they don't lower prices for medicines in the US. Shares in Novo Nordisk, the Danish maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, saw shares drop 4.5% shortly after trading got under way in Copenhagen. Shares in Britain's AstraZeneca fell 2.8% in London, while Sanofi fell 1.1% in Paris. Meanwhile shares in Novartis shed 0.9% and Roche 1.0% after Trump announced Swiss goods will face a 39% tariff starting next week. Trump told major pharmaceutical firms Thursday to lower prices or face punishment, as he moved to give Americans relief from medicine costs much higher than elsewhere in the world. In letters to 17 drug companies published on his platform Truth Social, Trump said he wants the firms to work with his administration to institute a series of changes within 60 days. 'If you refuse to step up we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices,' Trump wrote without specifying what the consequences would entail. Trump is following up on an executive order he signed in May to address US drug prices that are among the highest in the world – more than three times what people in similarly developed countries pay, the White House said Thursday.


Free Malaysia Today
12 hours ago
- Free Malaysia Today
Trump warns pharma companies to cut prices or be punished
US drug prices are more than three times what people in similarly developed countries pay. WASHINGTON : US President Donald Trump told major pharmaceutical firms Thursday to lower prices or face punishment, as he moved to give Americans relief from medicine costs much higher than elsewhere in the world. In letters to 17 drug companies published on his Platform Truth Social, Trump said he wants the firms to work with his administration to institute a series of changes within 60 days. 'If you refuse to step up we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices,' Trump wrote without specifying what the consequences would entail. Trump is following up an on executive order he signed in May to address US drug prices that are among the highest in the world – more than three times what people in similarly developed countries pay, the White House said Thursday. In the letters Trump said the response he has received so far to his order from companies have been 'more of the same: shifting blame' and policy changes that would in fact benefit the industry, not consumers. Key to the Trump plan is a 'Most Favored Nation' policy that pins the cost of drugs sold in the US to the lowest price paid by other countries for the same drug. Trump said Thursday he wants the companies to extend this pricing policy to medications used by older people under the government-backed health program Medicaid. He also wants this status to apply to new drugs, Trump said in the letters. 'Americans are demanding lower drug prices and they need them today,' Trump wrote.


Free Malaysia Today
18 hours ago
- Free Malaysia Today
Amazon shuts down Shanghai AI lab
Amazon Web Services has announced job cuts across its operations, with some reports putting the losses at hundreds. (EPA Images pic) SHANGHAI : US tech giant Amazon has shut down its artificial intelligence (AI) research lab in Shanghai, a source with direct knowledge of the matter confirmed to AFP. News that the lab, part of the cloud division Amazon Web Services (AWS), has closed comes with AI at the forefront of a tech race between China and the US. In a screenshot of a WeChat post widely circulated on Chinese social media this week, Wang Minjie, a scientist at the lab, said its disbanding was 'due to the strategic adjustment between China and the US'. AWS announced job cuts across its operations last week, with some reports putting the losses at hundreds. Amazon declined to confirm the Shanghai lab's closure directly when contacted by AFP. 'We've made the difficult business decision to eliminate some roles across particular teams in AWS,' spokesman Brad Glasser said in a similar statement to the one released in response to the broader job losses. 'These decisions are necessary as we continue to invest, hire, and optimise resources to deliver innovation for our customers,' he said. A dedicated AWS China webpage for the lab seen on Wednesday by AFP was no longer accessible on Friday. According to an archive of the page, the lab was established in autumn 2018, with part of its remit to 'actively foster collaboration with the research community'. Other US tech firms such as Microsoft and IBM have scaled back their research divisions in China recently, as the tech competition between Washington and Beijing shows no sign of abating.